ARCHIVES

PI Defends NCI’s National Lung Screening Trial As “Rigorous” Randomized Trial.

This article is from The Cancer Letter archive.

Vol. 32 No. 39 | November 3, 2006

Download PDF Visit The Full Archive

Related Articles

NCI director creates four new deputy director positions to manage the Institute.

February 20, 2004

Obama Picks Hamburg for FDA Commissioner

March 20, 2009

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998

14th Cancer Congress Big Success; CICA Satellite Established; US, USSR Renew Cancer Agreement

September 12, 1986

FDA Orders More Changes In ESA Label,

August 8, 2008

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006